CAI

Caris Life Sciences Inc.

Caris Life Sciences Publishes Study Showing Whole Exome Measurement of Tumor Mutational Burden Results in Increased Overall Survival Compared to Estimates from Targeted Gene Panels Caris Life...

Caris Life Sciences Submits Application to New York State Department of Health for Caris Assure BloodBased Testing Authorization Caris Life Sciences Submits Application to New York State Department of Health for Caris Assure BloodBased Testing Authorization PR Newswire IRVING, Texas, May 8, 2026...

(RTTNews) - Caris Life Sciences (CAI) on Thursday reported first-quarter results with revenue rising sharply from last year while losses narrowed, driven by strong growth in molecular profiling services...

Caris Life Sciences Reports First Quarter 2026 Financial Results Caris Life Sciences Reports First Quarter 2026 Financial Results PR Newswire IRVING, Texas, May 7, 2026 Revenue growth of 79% driven...

UBS Group AG lifted its stake in shares of Caris Life Sciences, Inc. (NASDAQ:CAI - Free Report) by 825.9% during the fourth quarter, according to the company in its most recent Form 13F filing with...

Caris Life Sciences Launches Caris MI Clarity, the First and Only AI-Powered Test to Predict Both Early and Late Distant Recurrence Risk in Breast Cancer at the Time of Diagnosis Caris Life Sciences Launches Caris MI Clarity, the First and Only AI-Powered Test to Predict Both Early and Late Distant...

Caris Life Sciences Receives MolDX Approval for Caris ChromoSeq, Advancing Access to Comprehensive Genomic Profiling for Myeloid Malignancies Caris Life Sciences Receives MolDX Approval for Caris...

Wall Street Zen lowered Caris Life Sciences from a "buy" rating to a "hold" rating in a report on Saturday...

Caris Life Sciences (NASDAQ:CAI) Shares Gap Down - Time to Sell...